Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Neuraxis (NRXS) EBIT Margin (2022 - 2025)

Neuraxis (NRXS) has disclosed EBIT Margin for 4 consecutive years, with 177.34% as the latest value for Q4 2025.

  • Quarterly EBIT Margin rose 1534.0% to 177.34% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 219.37% through Dec 2025, up 4709.0% year-over-year, with the annual reading at 219.37% for FY2025, 4709.0% up from the prior year.
  • EBIT Margin hit 177.34% in Q4 2025 for Neuraxis, up from 258.82% in the prior quarter.
  • In the past five years, EBIT Margin ranged from a high of 98.1% in Q2 2022 to a low of 633.0% in Q3 2023.
  • Historically, EBIT Margin has averaged 243.02% across 4 years, with a median of 194.43% in 2022.
  • Biggest five-year swings in EBIT Margin: crashed -43858bps in 2023 and later surged 38530bps in 2024.
  • Year by year, EBIT Margin stood at 160.86% in 2022, then crashed by -90bps to 305.42% in 2023, then soared by 37bps to 192.68% in 2024, then grew by 8bps to 177.34% in 2025.
  • Business Quant data shows EBIT Margin for NRXS at 177.34% in Q4 2025, 258.82% in Q3 2025, and 192.14% in Q2 2025.